Morning Wrap
Today’s Newsflow
Select headline to navigate to article
Economic View Stunning SYRIZA victory to bring things to
a head
Kingspan Confirms advanced talks with Joris Ide Group
over potential bolt-on acquisition
CRH Press speculation that CRH has teamed up with KKR
for Holcim Lafarge bid
Equity Research
26 Jan 2015
Upcoming Events
Company Events
26-Jan
27-Jan
28-Jan
29-Jan
30-Jan
02-Feb
Cranswick; Q3 2015 results
Carpetright; Q4 2014 Results
easyJet; Q1 2015 Results
Greencore; AGM
International Paper; Q4 2014 Results
CPL Resources; 2015 Interim Results
Diageo; Q2 2015 Results
Mitchells & Butlers; AGM
Fuller Smith & Turner PLC; Q3 2015 Results
Ryanair; Q3 2015 Results
Economic Events
Ireland
01-Feb
Unemployment Rate Jan 2015
United Kingdom
26-Jan
BBA Mortgage Approvals Dec 2014
United States
Europe
Goodbody Capital Markets
Equity Research +353 1 6419221
Equity Sales +353 1 6670222
Bloomberg GDSE<GO>
Goodbody Stockbrokers (trading as Goodbody) is regulated by the Central Bank of Ireland. For the attention of US clients of Goodbody
Securities Inc, this third-party research report has been produced by our affiliate Goodbody Stockbrokers. Please see the end of this
report for analyst certifications and other important disclosures.
Goodbody Morning Wrap
Economic View Stunning SYRIZA victory to bring things to a head
Yesterday’s Election in Greece, where the anti-austerity party Syriza won 36% of the vote,
will have implications well beyond that country. While Syriza will fall two seats short of an
overall majority, it is highly likely that Alexis Tsipras will be sworn in as Prime Minister of a
coalition government over the coming days. Laying out his stall in his victory speech last
night, Tsipras stated that the “mandate of the Greek people today cancels, in an indisputable
way, the memorandums”. He added that it makes “the Troika a thing of the past”.
While one would expect these types of comments given the campaign platform of the party,
the gauntlet has been clearly put down to the EU, IMF and ECB. Significantly, Tsipras has a
much stronger hand to play than his predecessor in 2012. This time around, Greece is
running a primary surplus (expected to be 4% of GDP this year), while the majority (80%) of
Greek debt is now held by official creditors.
The coming weeks will thus be about who plays their hand best around the negotiating table.
The new Greek government knows it has the mandate from its people to renegotiate its
bailout programme, including its large debt burden. European leaders do not want a return of
the uncertainty of 2012 and also know that it must be careful not to set a precedent for
other countries who may also seeking some form of debt relief from Europe (Spain and
Ireland most prominently). The ECB has already said that it will not play any part in a Greek
debt restructuring.
The middle ground for both sides appears to be some form of restructuring of the
official loans, by way of extension, interest holidays or interest rate reductions. In
some ways, bringing these issues to a head in Greece could be a positive
development, as Greek debt, at 170% of GDP is clearly unsustainable. It may be a
volatile few weeks though before we get to that position.
Home…
Page 2
26 Jan. 15
Dermot O’Leary
+353-1-641 9167
[email protected]
Goodbody Morning Wrap
Kingspan Confirms advanced talks with Joris Ide Group over potential bolt-on acquisition
Following media speculation over the weekend Kingspan has this morning confirmed that it is
Recommendation: Buy
in negotiations to acquire Joris Ide Group. This is a business headquartered in Belgium and is
Closing Price: €15.40
a leading manufacturer of steel profiles and insulated panels. In addition to a strong position
in its home market of Belgium the business also has significant market positions in France
and Eastern Europe.
Robert Eason
+353-1-641 9271
[email protected]
Kingspan has given no financial details but according to a Mergermarket's article the
business has EBITDA of €36-37m. While we can't confirm these figures, we estimate that the
proforma net debt to EBITDA based on 2015 forecasts would be circa 2x (including Vicwest
which is to be acquired for circa €110m subject to competition clearance ), which is a
comfortable level of leverage.
Strategically the acquisition would complement Kingspan's existing mainland
European insulated panel business which now has estimated sales of €500m
following the Thyssenkrupp acquisition in 2012. It is this ability to utilise one of
the strongest balance sheets in the building materials sector coupled with
continued increases in penetration rates in end markets that underpins our positive
stance on the stock.
Home…
CRH Press speculation that CRH has teamed up with KKR for Holcim Lafarge bid
Press speculation over the weekend reported that CRH have teamed up with KKR, an
American private equity firm, in its bid for €6bn worth of Holcim Lafarge assets. The report
Recommendation: Buy
Closing Price: €22.35
suggests, CRH has held discussions with KKR about an agreement for the private equity firm
to take control of some divisions to assuage regulator concerns in the event of a successful
bid. It is reported that KKR are particularly interested in the UK assets, which ties in with our
view that these do not appeal to CRH.
Our working assumption is that CRH will not increase leverage above net
debt/EBITDA of 2.5x, with a potential equity placing beyond this level. Based on a
purchase multiple of 8-10x, we calculate that the level of earnings accretion would
be between 10-20% before any synergies.
Home…
Page 3
26 Jan. 15
Robert Eason
+353-1-641 9271
[email protected]
Goodbody Morning Wrap
Market Data
Top 10 Covered Companies
Company
AIB Group
Price
Mkt Cap
(LC)
(LCM)
1 Day
Absolute
1 Week
Relative to European Sector
1 Mth
P/E
Ytd
1 Day
1 Week
1 Mth
Ytd
2015f
2016f
0.08
42,404
2.5
8.0
1.3
2.5
0.8
2.8
-5.9
-5.2
45.0
54.4
CRH
22.35
16,552
3.8
12.7
12.5
12.3
2.0
7.2
4.5
3.9
22.9
18.6
Ryanair
10.34
14,305
2.2
7.2
6.2
5.5
0.4
2.0
-1.4
-2.5
16.8
13.8
Wolseley
39.99
10,659
1.4
10.1
7.7
8.5
-0.4
4.8
0.1
0.3
17.7
15.2
5.36
9,945
2.1
9.1
13.1
10.3
0.4
3.8
5.1
2.0
n/m
n/a
65.19
11,460
4.3
5.4
10.2
14.2
2.5
0.3
2.4
5.6
21.8
19.6
IAG
Kerry Group
Bank of Ireland
0.29
9,391
-5.2
-4.6
-8.8
-7.3
-6.8
-9.2
-15.3
-14.3
11.6
10.5
easyJet
17.35
6,819
1.5
8.4
4.0
3.8
-0.3
3.2
-3.4
-4.0
12.8
12.1
Mondi
11.50
5,584
1.1
8.2
7.6
9.5
-0.7
2.9
-0.1
1.3
13.9
13.1
Lufthansa
14.90
6,896
-1.7
4.6
7.5
7.7
-3.4
-0.5
-0.1
-0.4
10.8
8.8
ISEQ performance
Indices
Price
1 Day
1 Week
1 Mth
Ytd
5,600
ISEQ
%
5,577.82
2.12
5.56
6.69
6.76
5,400
FTSE 100
6,832.83
0.53
4.31
3.56
4.06
DAX 30
10,649.58
2.05
4.74
7.33
8.61
CAC 40
4,640.69
1.93
5.96
7.55
8.61
FTSE Eurofirst 300
1,479.51
1.80
5.14
7.62
8.11
Nasdaq
4,757.88
0.16
2.66
-0.16
0.46
S&P 500
2,051.82
-0.55
1.60
-1.46
-0.34
4,400
Dow Jones
17,672.60
-0.79
0.92
-1.95
-0.84
Nikkei 225
17,511.75
1.05
3.84
-0.70
0.35
4,200
Jan-14
Px 1 day Px 1 Week
5,200
5,000
4,800
4,600
Apr-14
Jul-14
Oct-14
Jan-15
Oct-14
Jan-15
Oct-14
Jan-15
Exchange Rates
Px Dec14
Avg Ytd
Stg/€
Current
0.749
0.757
0.761
0.776
0.772
US$/€
1.125
1.142
1.150
1.210
1.173
CHF/€
JPY/€
STOXX 600 performance
0.987
0.994
0.981
1.202
1.121
380
132.547
134.623
135.245
145.079
138.961
370
360
Bonds
350
Yield
1 Day
Yld 1 Wk
Yld 1 Mth
Yld 3 Mth
US 2 Yr
0.49
-0.03
0.49
-0.26
0.10
US 10 Yr
1.79
-0.07
-0.05
-0.47
-0.48
UK 2 Yr
0.32
-0.02
-0.07
-0.13
-0.27
UK 10 Yr
1.48
-0.04
-0.06
-0.37
-0.76
BD 2 Yr
340
330
320
310
Jan-14
-0.17
0.01
-0.01
-0.17
-0.12
BD 10 Yr
0.32
-0.07
-0.09
0.32
-0.54
Irish 10 Yr
0.90
-0.07
-0.14
-0.36
-0.93
Current
1 day
5 day
1 Mth
1 Yr
48.79
0.56
-2.75
-20.91
-54.65
Gasoline (NYM $/Gal)
1.35
1.28
-0.80
-14.17
-49.36
Heat Oil (NYM $/Gal)
1.62
0.66
-2.67
-16.94
-45.80
16,000
15,500
Commodities
%
Brent (ICE $/bbl)
Nat.Gas
Gold $/oz
Silver $/ozt
Copper U$/MT
Wheat $/BU
Source : FactSet
Page 4
26 Jan. 15
Apr-14
Jul-14
FTSE 250 performance
2.99
5.33
-4.51
-5.83
-36.87
1,294.75
-0.08
1.35
10.12
2.51
18.23
0.83
7.74
16.04
-9.35
5,581.00
-2.80
-1.40
-12.29
-23.39
5.30
-0.70
-0.52
-16.60
-7.02
17,000
16,500
15,000
14,500
14,000
Jan-14
Apr-14
Jul-14
Goodbody Morning Wrap
Issuer & Analyst Disclosures
Analyst Certification
The named Research Analyst certifies that: (1) All of the views expressed in this research report accurately reflect my personal views about
any and all of the subject securities and issuers. (2) No part of my remuneration was, is, or will be, directly or indirectly, related to the
specific recommendations or views expressed by me in this report.
Regulatory Information
Goodbody Stockbrokers, trading as Goodbody, is regulated by the Central Bank of Ireland. Goodbody is a member of the Irish Stock
Exchange and the London Stock Exchange. Goodbody is a member of the FEXCO group of companies. This publication has been approved by
Goodbody Stockbrokers. The information has been taken from sources we believe to be reliable, we do not guarantee their accuracy or
completeness and any such information may be incomplete or condensed. All opinions and estimates constitute best judgement at the time
of publication and are subject to change without notice. The information, tools and material presented in this document are provided to you
for information purposes only and are not to be used or considered as an offer or the solicitation of an offer to sell or to buy or subscribe for
securities.
Conflicts of Interest
Goodbody Stockbrokers has procedures and policies in place to identify and manage any potential conflicts of interest that arise in
connection with its research business. Goodbody Stockbrokers’ analysts and other staff who are involved in the preparation and
dissemination of research operate and have a management reporting line that is independent to its Corporate Finance business. Information
barriers are in place between the Corporate Finance arm and the Research arm to ensure that any confidential and or price sensitive
information is handled in an appropriate manner.
Our Investment Research Conflicts of Interest Policy is available at Conflicts of Interest
Investors should be aware, that, where appropriate, research may be disclosed to the issuer(s) in advance of publication in order to correct
factual inaccuracies only and not to materially amend the research in any way. Goodbody Stockbrokers is satisfied that it has operational
procedures in place, which ensure that such disclosures will not compromise the report’s objectivity.
Goodbody Stockbrokers and its associated companies may from time to time perform investment banking or corporate finance services,
including underwriting, managing or advising on a public offering for, or solicit business from any company recommended in this report.
Goodbody Stockbrokers may have acted, in the past 12 months, as lead manager / co-lead manager in the securities of any company
named in this report.
Goodbody was the co-lead manager for Hibernia REIT Plc for a public fund raising in the past 12 months.
Goodbody Stockbrokers acts as corporate broker to AIB Group, Datalex, FBD Holdings, First Derivatives, Grafton Group, Greencore, Hibernia
REIT, ICG, Kingspan, Origin Enterprises, Paddy Power, UDG Healthcare, and UTV Media
Goodbody Stockbrokers is a registered market maker in the majority of companies listed on the Irish Stock Exchange and their equivalent
on the London Stock Exchange and may hold positions in any of the companies mentioned in this report from time to time. A complete list of
the companies that Goodbody Stockbrokers makes a market in is available at Regulatory Disclosures
Page 5
26 Jan. 15
Goodbody Morning Wrap
Other disclosures
We would like to inform you that Robert Eason holds shares in Kingspan
A description of this company is available at Company Descriptions
All prices used in this report are as at close of business of the previous working day unless otherwise indicated.
A summary of our standard valuation methods are available at Valuation Methodologies
A summary of share price recommendations and whether material investment banking services have been provided to these companies is
available at Regulatory Disclosures
Other important disclosures are available at Regulatory Disclosures
Goodbody Stockbrokers updates its recommendations on a regular basis. A breakdown of all recommendations provided by Goodbody
Stockbrokers is available at Regulatory Disclosures Where Goodbody Stockbrokers has provided investment banking services to an issuer,
details of the proportion of buys, holds and sells attributed to that issuer will also be included. This is updated on a quarterly basis.
The date on which stock recommendations were first released for all stocks mentioned in this report are available at
http://www.goodbody.ie/research_disclosures/regulatorydisclosures/index.html. If a different recommendation has been made in the
previous twelve months, this will also be disclosed here.
Recommendation Definitions
Goodbody Stockbrokers uses the terms “Buy”, “Sell” and “Hold. The term “Buy” means that the analyst expects the security to appreciate in
excess of 10% over a twelve month period. The term “Sell” means that the security is expected to decline in excess of 10% over the next
twelve months. The term “Hold” means that the analyst expects the security to neither appreciate more than 10%, or depreciate more than
10% over the next twelve months.
On 26th November, 2012, the terms “Add” and “Reduce” were removed from the Recommendation Definitions and both were replaced with
the “Hold” recommendation. Any Previous Recommendation that refers to either an “Add” means that the analyst expected the security to
appreciate by up to 15% over a twelve month period. Any Previous Recommendation to “Reduce” means that the analyst expected the
security to decline by up to 15% over the next twelve months.
In the event that a stock is delisted the firm will automatically cease coverage. If however the firm ceases to cover a stock for any other
reason the firm will disclose this fact.
Distribution of research to clients of Goodbody Securities Inc (GSI) in the US
GSI distributes third-party research produced by its affiliate, Goodbody Stockbrokers
GSI is a member of FINRA and SIPC
GSI does not act as a market-maker.
This information was current as of the last business day of the month preceding the date of the report.
An affiliate of GSI may have acted, in the past 12 months, as lead manager/co-lead manager of a publicly disclosed offer of the securities in
this company. Investors should be aware that an affiliate of GSI may have provided investment banking or non-investment-banking services
to, and received compensation from this company in the past 12 months or may provide such services in the next three months. The term
investment banking services includes acting as broker as well as the provision of corporate finance services, such as underwriting and
managing or advising on a public offer. All transactions by US persons involving securities of companies discussed in this report are to be
effected through GSI.
Disclaimer
While all reasonable care has been taken in the production and dissemination of this report it is not to be relied upon in
substitution for the exercise of independent judgement. Nothing in this report constitutes investment, legal, accounting or tax
advice, or a representation that any investment or strategy is suitable or appropriate to your individual circumstances, or
otherwise constitutes a personal recommendation to you.
Private customers having access, should not act upon it in anyway but should consult with their independent professional
advisors. The price, value and income of certain investments may rise or may be subject to sudden and large falls in value.
You may not recover the total amount originally invested. Past performance should not be taken as an indication or guarantee
of future performance; neither should simulated performance. The value of securities may be subject to exchange rate
fluctuation that may have a positive or adverse effect on the price or income of such securities.
All material presented in this report, unless specifically indicated otherwise is copyright to Goodbody Stockbrokers. None of the material, nor
its content, nor any copy of it, may be altered in any way, transmitted to, copied or distributed to any other party, without the prior express
written permission of Goodbody Stockbrokers.
Goodbody, Ballsbridge Park, Ballsbridge, Dublin 4, Ireland
T
(+353 1) 6670400
W
www.goodbody.ie
E
[email protected]
Page 6
26 Jan. 15